Log in
Enquire now
NexImmune

NexImmune

NexImmune is a biotechnology company developing immuno-therapeutics for cancer, inflammatory and viral diseases.

OverviewStructured DataIssuesContributors

Contents

neximmune.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Stem cell
Stem cell
Immunotherapy
Immunotherapy
Biopharmaceutical
Biopharmaceutical
Biomedical engineering
Biomedical engineering
Technology
Technology
Biology
Biology
...
Location
United States
United States
Gaithersburg, Maryland
Gaithersburg, Maryland
0
CEO
‌
Kristi Jones
0
AngelList URL
angel.co/neximmune
Pitchbook URL
pitchbook.com/profiles.../65159-02
Legal Name
NexImmune, Inc.
Date Incorporated
2011
Number of Employees (Ranges)
51 – 2000
Phone Number
+130182598100
Number of Employees
740
Full Address
9119 Gaither Road, Gaithersburg, Maryland 20877, US
9119 Gaither Road Gaithersburg, MD 208770
CIK Number
1,538,2100
Place of Incorporation
Delaware
Delaware
0
Investors
Amgen Ventures
Amgen Ventures
DUNS Number
968596267
Founded Date
2011
Total Funding Amount (USD)
1,000
Latest Funding Round Date
June 7, 2011
Stock Symbol
NEXI0
Exchange
Nasdaq
Nasdaq
0
Board of Directors
‌
Sol J. Barer
0
‌
Tim Bertram
0
‌
Kristi Jones
0
‌
Grant Verstandig
0
‌
Alan S. Roemer
0
‌
Leena Gandhi
0
‌
Paul D’Angio
0
CFO
‌
John Trainer
0
Latest Funding Type
Seed
Seed
Patents Assigned (Count)
2
Wellfound ID
neximmune
Country
United States
United States
0

Other attributes

Company Operating Status
Active
Contact Page URL
neximmune.com/contact/
Public/Private
Public
SIC Code
2,8340
Ticker Symbol
NEXI
Wikidata ID
Q30288362

NexImmune is a biotechnology company developing immunotherapies that is headquartered in Gaithersburg, Maryland and was founded in 2011 by Jonathan Schneck.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

NexImmune Acquired by a Consortium of Private Investors Led by Former Celgene and Medtronic CEOs

Globe Newswire

https://www.cnbc.com/2017/02/14/globe-newswire-neximmune-acquired-by-a-consortium-of-private-investors-led-by-former-celgene-and-medtronic-ceos.html

Web

NexImmune Announces $3 Million Financing

NEA

https://www.nea.com/news/press-releases/neximmune-announces-3-million-financing

Web

NexImmune Granted Key US Patent for Core E+E Technology

Neximmune

https://www.globenewswire.com/news-release/2018/12/11/1665070/0/en/NexImmune-Granted-Key-US-Patent-for-Core-E-E-Technology.html

Web

NexImmune Raises $23 Million to Advance Endogenous Cellular ImmunoTherapy into Clinical Development

Neximmune

https://www.globenewswire.com/news-release/2018/01/02/1276945/0/en/NexImmune-Raises-23-Million-to-Advance-Endogenous-Cellular-ImmunoTherapy-into-Clinical-Development.html

Web

References

Find more companies like NexImmune

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.